Atypical Fibroxanthoma
Author Information
Author(s): Sakamoto Akio
Primary Institution: Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Hypothesis
AFX is considered to be a different lesion from malignant fibrous histiocytoma (MFH) and may share similar pathways in morphology but differ in biological behavior.
Conclusion
AFX is now believed to be a benign lesion centered in the dermis in sun-exposed skin, particularly in the elderly or individuals with conditions that impair DNA repair.
Supporting Evidence
- AFX is characterized by its association with ultraviolet radiation.
- Making a diagnosis of AFX is challenging and requires histological features and immunohistochemical markers.
- AFX typically occurs on sun-exposed skin in elderly individuals.
- About half of AFX cases are ulcerated.
- AFX is considered to be a benign lesion with a low recurrence rate.
Takeaway
Atypical fibroxanthoma is a type of skin growth that usually happens on sun-exposed areas and is more common in older people. It's important to tell it apart from other skin cancers.
Methodology
The study involved a review of clinical and histopathological features of atypical fibroxanthoma cases.
Limitations
The study may not cover all variants of atypical fibroxanthoma and relies on previously reported cases for some data.
Participant Demographics
The average age of participants was 71.9 years, with a predominance of men (70%).
Want to read the original?
Access the complete publication on the publisher's website